Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 5 49-5, 2001, Pages

  Cho, Michael ^a   Hunt, Thomas K ^a   Hussain, M Zamirul ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Antioxidant; Neutrophil; Oxidative stress; Wound healing

Indexed keywords

ANTIOXIDANT; CATALASE; DACTINOMYCIN; DNA; HYDROGEN PEROXIDE; MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MACROPHAGE FUNCTION; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; WOUND HEALING;

EID: 0035039359     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.5.h2357     Document Type: Article

References (41)

1. Allen DB, Maguire JJ, Mahdavian M, Wicke C, Marcocci L, Scheuenstuhl H, Chang M, Le AX, Hopf HW, and Hunt TK. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg 132: 991-996, 1997.
2. Bergren CT, Bodzin JH, and Cortez JA. Improved survival using oxygen free radical scavengers in the presence of ischemic bowl anastomosis. Am Surg 54: 333-336, 1988.
3. Bhopale KK, Masani KB, Pradhan KS, and Kaul CL. A simple quantitative in vitro macrophage migration assay. Indian J Exp Biol 34: 968-977, 1996.
4. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 271: 21793-21797 1996.
5. Claffey KP, Shih SC, Mullen A, Dziennis S, Cusick JL, Abrams KR, Lee SW, and Detmar M. Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol Biol Cell 9: 469-481, 1998.
6. Cunningham FM, Smith MJ, Ford-Hutchinson AW, and Walker JR. Migration of peritoneal polymorphonuclear leucocytes in the rat. J Pathol 128: 15-20, 1979.
7. Fantone JC and Ward PA. Polymorphonuclear leukocyte-media cell and tissue injury: oxygen metabolites and their relations to human disease. Hum Pathol 16: 973-978, 1985.
8. Frater-Schroder M, Risau W, Hallmann P, Gautschi R, and Bohlen P. Tumor necrosis factor type-alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 84: 5277-5281, 1987.
9. Gardner TJ, Steward JR, and Casale AS. Reduction of myocardial ischemic injury with oxygen-derived free radical scavengers. Surgery 94: 423-427, 1983.
10. Gibson GJ, Sheik AY, Rollins MD, Hopf HW, and Hunt TK. Increased oxygen tension and wound fluid vascular endothelial growth factor levels. Surg Forum 49: 607-610, 1998.
11. Hamilton TA and Adams DO. Molecular mechanisms of signal transduction in macrophages. Immunol Today 8: 151-158, 1987.
12. Harris P and Ralph P. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J Leukoc Biol 37: 407-422, 1985.
13. Hogstrom H. Mechanisms and prevention of decrease in wound margin strength in intestinal anastomoses and laparotomy wounds. Acta Chir Scand 539: 1-63, 1987.
14. Hyslop PA and Sklar LA. A quantitative fluorimetric assay for the determination of oxidant production by polymorphonuclear leukocytes: its use in the simultaneous fluorimetric assay of cellular activation processes. Anal Biochem 141: 280-286, 1984.
15. Jensen J, Hunt TK, Scheuenstuhl H, and Banda MJ. Effect of lactate, pyruvate, and pH on secretion of angiogenesis and mitogenesis factors by macrophages. Lab Invest 5: 573-578, 1986.
16. Johnson JL, Moore EE, Hiester AA, and Tamura DY. Disparities in the respiratory burst between human and rat neutrophils. J Leukoc Biol 65: 211-216, 1999.
17. Knighton DR, Hunt TK, Scheuenstuhl H, Halliday BJ, Web Z, and Banda MJ. Oxygen tension regulates the expression of angiogenesis factors by macrophages. Science 221: 1283-1285, 1983.
18. Koch A, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Einer VM, Elner SG, and Strieter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798-1801, 1992.
19. Koren HS, Anderson SJ, and Larrick JW. In vitro activation of a human macrophage-like cell line. Nature 279: 328-330, 1979.
20. Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M, Kim RY, Rohan RM, Colby KA, and Yeo KT. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 98: 1667-1675, 1996.
21. Levy AP, Levy NS, Wegner S, and Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270: 13333-13340, 1995.
22. Levy NS, Chung S, Furneaux H, and Levy AP. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA binding protein HuR. J Biol Chem 273: 6417-6423, 1998.
23. Liu Y, Cox SR, Morita T, and Kourembanas S. Hypoxia regulated vascular endothelial growth factor gene expressio in endothelial cells. Circ Res 77: 638-643, 1995.
24. Melikian V, Laverson S, and Zawacki B. Oxygen-derived free radical inhibition in the healing of experimental zone of stasis burns. J Trauma 27: 151-154, 1987.
25. Okada Y, Kimura T, Kameoka M, Kishi M, Azuma I, and Ikuta K. Viral activation from latency during retrodifferentiation of U937 cells exposed to phorbol ester followed by infection with human immunodeficiency virus type 1. Immunopharmacology 30: 27-39, 1995.
26. Parks DA, Bulkley GB, and Granger DN. Role of oxygen free radicals in digestive tract diseases. Surgery 94: 415-422, 1983.
27. Ruef J, Hu ZY, Yin LY, Wu Y, Hanson SR, Kelly AB, Harker LA, Rao GN, Runge MS, and Patterson C. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. Circ Res 81: 24-33, 1997.
28. Ruotsalainen M, Hyvarinen A, Nevalainen A, and Savolainen KM. Production of reactive oxygen metabolites by opsonized fungi and bacteria isolated from indoor air, and their interactions with soluble stimuli, fMLP or PMA. Environ Res 69: 122-131, 1995.
29. Ryuto M, Ono M, Hiroto I, Yoshida S, Weich HA, Kohno K, and Kuwano M. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. J Biol Chem 271: 28220-28228, 1996.
30. Schacter E, Beecham EJ, Covey JM, Kohn KW, and Potter M. Activated neutrophils induce prolonged DNA damage on neighboring cells. Carcinogenesis 9: 2297-2304, 1988.
31. Schraufstatter I, Hyslop PA, Jackson JH, and Cochrane CG. Oxidant-induced DNA damage of target cells. J Clin Invest 82: 1040-1050, 1988.
32. Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG, and Cochrane CG. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J Clin Invest 77: 1312-1320, 1986.
33. Senel O, Cetinkale O, Ozbay G, Ahcioglu F, and Bulan R. Oxygen free radicals impair wound healing in ischemic rat skin. Ann Plast Surg 39: 516-523, 1997.
34. Shandall AA, Williams GT, and Hallett MB. Colonic healing: a role for polymorphonuclear leukocytes and oxygen radical production. Br J Surg 73: 225-228, 1986.
35. Shima DT, Deutsch U, and D'Amore PA. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 370: 203-208, 1995.
36. Shima DT, Kuroki M, Deutsch U, Ng YS, Adamis AP, and D'Amore PA. The mouse gene for vascular endothelial growth factor. J Biol Chem 271: 3877-3883, 1996.
37. Sun Y and Oberley LW. Redox regulation of transcriptional activators. Free Radic Biol Med 21: 335-348, 1996.
38. Volk T, Ioannidis I, Hensel M, deGroot H, and Kox WJ. Endothelial damage induced by nitric oxide: synergism with reactive oxygen species. Biochem Biophys Res Commun 213: 196-203, 1995.
39. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 320: 365-376, 1989.
40. White MJ and Heckler FR. Oxygen free radicals and wound healing. Clin Plast Surg 17: 473-484, 1990.
41. Wu X, Bishopric NH, Discher DJ, Murphy BJ, and Webster KA. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol Cell Biol 16: 1035-1046, 1996.